Regenix Drugs Limited, a active public limited company, was established on 10 May 2007 in Chennai, Tamil Nadu, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U24232TN2007PLC063446. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹21.55 Cr and a paid-up capital of ₹18.08 Cr.
Formerly known as Regenix Drugs Private Limited. It upholds a compliant status. Employing 830 professional, Its leadership includes Malathi Ramamurthy (Director), Ayyamperumal (Director), Krishanamoorthy Nirosha (Whole-Time Director). Past directors included Jerome Zacharias, Saleem Mohamed Mohamed Haniffa, Ravindran Kumeran. It holds ₹11.86 Cr open charges and ₹17.81 Cr settled loans. Its latest AGM occurred on 22 September 2024, with the balance sheet filed on 31 March 2024. It is based at Jamal Sonu Terrace, 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.
U24232TN2007PLC063446
063446
10 May 2007
₹21.55 Cr
₹18.08 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Regenix Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Malathi Ramamurthy | Director | 15 Apr 2012 | Current |
| Ayyamperumal | Director | 26 Aug 2019 | Current |
| Krishanamoorthy Nirosha | Whole-Time Director | 21 Jun 2021 | Current |
| Guhan Ramamurthy | Director | 21 Jun 2021 | Current |
| Balaji Ramamurthy | Whole-Time Director | 01 Oct 2022 | Current |
| Govindarajan Venkatakrishna | Director | 20 Mar 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Jun 2008 | Past |
| Pramod Abcsdd | Director | 22 Aug 2022 | Past |
| Pramod Abcsdd | Director | 15 Apr 2012 | Past |
| Pramod Abcsdd | Director | 15 Apr 2012 | Past |
| Pramod Abcsdd | Additional Director | 01 Oct 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Regenix Drugs Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.7% increase. The company also saw a slight improvement in profitability, with a 0.3% increase in profit. The company's net worth Soared by an impressive increase of 17.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Regenix Drugs had a promoter holding of 62.97% and a public holding of 37.03%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹118,609,222.00
₹178,148,245.38
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Hdfc Bank Limited | ₹5.12 M | Open |
| 05 Sep 2023 | Hdfc Bank Limited | ₹2.12 M | Open |
| 13 Jul 2020 | Hdfc Bank Limited | ₹10.99 Cr | Open |
| 29 Jul 2015 | Axis Bank Limited | ₹1.47 M | Open |
| 17 Jul 2017 | Others | ₹7.99 Cr | Satisfied |
Explore comprehensive loan charge details -
Regenix Drugs has a workforce of 830 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Regenix Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited of Rs. 10.99 Cr registered on 13 Jul 2020 with Charge ID 100362965 was modified on 21 Jan 2025. was documented.
The activity Regenix Drugs Limited last Annual general meeting of members was held on 22 Sep 2024 as per latest MCA records. was completed.
The activity Regenix Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.51 Cr with Charge ID 100907370 was registered on 10 Jan 2024. was documented.
Progress on Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 24 Sep 2023 & has been associated with this company since 2 years 2 months . was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100786726 was registered on 05 Sep 2023. was documented.
The CIN of Regenix Drugs Limited is U24232TN2007PLC063446.
Regenix Drugs Limited is headquartered at Jamal Sonu Terrace, 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.
Regenix Drugs Limited was incorporated on 10 May 2007.
The current directors of Regenix Drugs Limited are
The primary industry of Regenix Drugs Limited is Manufacturing.
Regenix Drugs Limited is unlisted.
The authorized capital of Regenix Drugs Limited is ₹21.55 Cr, and the paid-up capital is ₹18.08 Cr.
The compliance status of Regenix Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX